Argus Investors' Counsel, Inc. Danaher Corp Transaction History

Argus Investors' Counsel, Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 19, 2024	BUY	$185.1 - $233.13 $22,026 - $27,742	119 Added 4.24%	2,925 $676,000
Q3 2023 Oct 17, 2023	SELL	$233.08 - $265.59 $102,788 - $117,125	-441 Reduced 13.58%	2,806 $696,000
Q2 2023 Jul 20, 2023	SELL	$224.99 - $256.14 $777,790 - $885,475	-3,457 Reduced 51.57%	3,247 $779,000
Q1 2023 Apr 20, 2023	BUY	$239.75 - $277.0 $28,290 - $32,686	118 Added 1.79%	6,704 $1.69 Million
Q4 2022 Jan 18, 2023	BUY	$241.42 - $282.29 $15,692 - $18,348	65 Added 1.0%	6,586 $0
Q3 2022 Oct 18, 2022	BUY	$247.06 - $1507.4 $91,659 - $559,245	371 Added 6.03%	6,521 $1.68 Million
Q2 2022 Jul 22, 2022	BUY	$237.11 - $299.66 $130,173 - $164,513	549 Added 9.8%	6,150 $1.56 Million
Q1 2022 May 04, 2022	BUY	$257.27 - $315.76 $792,906 - $973,172	3,082 Added 122.35%	5,601 $1.64 Million
Q4 2021 Jan 25, 2022	BUY	$292.08 - $329.01 $184,302 - $207,605	631 Added 33.42%	2,519 $829,000
Q3 2021 Oct 20, 2021	BUY	$272.21 - $332.43 $113,511 - $138,623	417 Added 28.35%	1,888 $575,000
Q2 2021 Jul 30, 2021	BUY	$225.08 - $271.69 $127,170 - $153,504	565 Added 62.36%	1,471 $395,000
Q1 2021 Apr 19, 2021	BUY	$212.38 - $245.9 $192,416 - $222,785	906 New	906 $204,000

2,508

542M

7.07M

4.55M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $171B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Argus Investors' Counsel, Inc., based on Form 13F filings with the SEC.

Stay updated on Argus Investors' Counsel, Inc. with notifications on news.